Dr Pramod Kabra takes charge as CEO of CPC Diagnostics

CPC Diagnostics, a Chennai-based provider of In-Vitro Diagnostics (IVD) products and services in India, Sri Lanka, Nepal and Bangladesh and the Indian subsidiary of Everlife Asia, has announced the appointment of Dr Pramod Kabra as the company’s Chief Executive Officer (CEO). Dr Kabra will be working closely with the Everlife team and local management to accelerate growth of the company by expanding reach and product offering, delivering superior performance to the partners and improving customer experience. He brings with him over 20 years of valuable and diverse industry experience notably in the Pharmaceutical, Diagnostic, and Clinical Research segments. Prior to joining CPC, he led the Specialty Diagnostics Group at Thermo Fisher Scientific. Throughout his career, Dr Kabra has demonstrated a proven track record of growing businesses, driving productivity and improving overall business performance. He is a trained physician and is frequently invited to share his expertise at industry conferences.